We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Nose and Throat Specimens Compared for Rapid Adenovirus Detection

By LabMedica International staff writers
Posted on 02 Dec 2014
Print article
TAUNS Laboratories\' Adenovirus antigen detection kit ImmunoAce Adeno
The Adenovirus antigen detection kit ImmunoAce Adeno (Photo courtesy of Tauns Laboratories)
The diagnosis of adenovirus infection on clinical grounds alone is sometimes difficult and now chromatographic immunoassay tests have begun to be available for point-of-care use.

Adenovirus is among the most common causes of upper respiratory tract infections in febrile pediatric outpatients throughout the year and rapid, accurate diagnosis is important because adenoviral diseases are often associated with prolonged, high-grade fever.

Scientists at the Hiroshima Prefectural Technology Research Institute (Japan) conducted a prospective study between September 2008 and July 2012 to determine whether nasopharyngeal aspirate (NPS) and throat swab (TS) specimens from individual patients could be compared with regard to usefulness for adenovirus detection.

One pediatrician collected TS and NPA specimens in parallel from outpatient children suspected of having adenovirus infection and performed the rapid diagnosis using a chromatographic immunoassay test, the ImmunoAce Adeno (TAUNS Laboratories, Inc.; Numazu, Japan). TS and NPA were tested in separate identical devices and each NPA swab was prepared after being dipped in NPA fluid. Aliquots of NPAs were stored at -70 °C until tested with culture and real-time polymerase chain reaction (PCR) assays to detect and identify adenovirus.

Among the 309 children enrolled, real-time PCR assay, which did not distinguish among serotypes, identified 153 patients with adenovirus and these were considered to be adenovirus-infected patients. Of these 153 patients, viral cultures identified 139 patients with adenovirus, including six serotypes, accounting for 90.8% of the adenovirus detection rate. Among the 153 adenovirus-positive specimens, based on real-time PCR findings, the sensitivities of the rapid test ImmunoAce Adeno were 91.5% for TS and 90.8% for NPA.

The authors concluded that the diagnostic accuracy between TS and NPA specimen types for the rapid diagnosis of adenovirus infections, and the detection rates between the two specimen types were nearly equivalent. Throat swabs are commonly used for the rapid diagnosis of adenoviral infections, while NPAs are routinely used for rapid detection of influenza virus. The present findings will be helpful for pediatricians in primary care clinics because they may be able to use the remaining NPA specimen for the detection of adenovirus or other respiratory viruses in cases when an influenza-negative result is unexpectedly obtained. The study was published on November 12, 2014, in the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

Hiroshima Prefectural Technology Research Institute
TAUNS Laboratories 


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Chagas Disease Test
LIAISON Chagas
New
Ultrasonic Cleaner
UC 300 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: The advanced molecular test is designed to improve diagnosis of a genetic form of COPD (Photo courtesy of National Jewish Health)

Groundbreaking Molecular Diagnostic Test Accurately Diagnoses Major Genetic Cause of COPD

Chronic obstructive pulmonary disease (COPD) and Alpha-1 Antitrypsin Deficiency (AATD) are both conditions that can cause breathing difficulties, but they differ in their origins and inheritance.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.